• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » J&J surgical stapler recall gets Class I status from the FDA | MassDevice.com On Call

J&J surgical stapler recall gets Class I status from the FDA | MassDevice.com On Call

October 29, 2012 By MassDevice staff

MassDevice On Call

MASSDEVICE ON CALL — Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon Endo-Surgery’s global surgical stapler recall got Class I status from the FDA over concerns that issues with the devices’ firing mechanisms may injure patients.

MassDevice.com in August reported on the recall, which involves certain lots of Ethicon’s Proximate PPH and HCS hemorrhoidal circular staplers and accessories, when the company notified authorities in Hong Kong of the recall.

J&J launched the recall over issues firing the device, which could result in incomplete staple formation, according to the Hong Kong letter.

"Failure to complete the firing stroke of the stapler can result in severe pain, sphincter dysfunction, rectal wall damage, sepsis, bleeding, and occlusion of the rectal canal," according to the FDA notice. "Failure to complete the firing stroke can also result in poor staple formation, dehiscence of the rectal wall staple line and bleeding."

The recall affects more than 157,000 surgical stapling systems distributed worldwide, the Wall Street Journal reported.

 South Dakota courts device makers
South Dakota government representatives are heading to Minnesota for the medical Design & Manufacturing Exposition in Minneapolis, hoping to lure device makers back to their home state.  
Read more

 New tech for cheaper home care
New technologies aim to provide lower-cost home care, including a wireless medical and home safety monitoring system with medication management and treatment plan compliance.
Read more

 Fresenius prepares for the storm
Dialysis-provider Fresenius (NYSE:FMS) activated its emergency response team to ensure that its service centers in the U.S. Northeast and Mid-Atlantic regions can stay up and running as Hurricane Sandy prepares to roll through.
Read more

 Healthcare as a job-growth driver
Missouri Governor Phil Bryant (R) wants to leverage the healthcare industry to drive job growth, including luring more doctors to the state, especially in rural areas.
Read more

Filed Under: Food & Drug Administration (FDA), News Well, Recalls, Surgical Tagged With: Ethicon, Johnson and Johnson, On Call

More recent news

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy